TQ-B3139 capsules

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQ-B3139 capsules, covering 2020-09-11 to 2020-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer [Phase 2]